Overview

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

Status:
Completed
Trial end date:
2021-08-24
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of vonoprazan compared to lansoprazole in participants with erosive esophagitis.
Phase:
Phase 3
Details
Lead Sponsor:
Phathom Pharmaceuticals, Inc.
Treatments:
Dexlansoprazole
Lansoprazole